The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer cells.
Saved in:
| Title: | The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer cells. |
|---|---|
| Authors: | Deserti M; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Sabbioni S; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Poli F; Pathology Unit, Azienda Unità Sanitaria Locale (AUSL) of Imola, Imola, Italy., Vasuri F; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.; Pathology Unit, Santa Maria delle Croci Ravenna Hospital, Ravenna, Italy., Relli V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Palloni A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Deiana C; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Brandi G; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Tavolari S; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Mar 02; Vol. 16, pp. 1713273. Date of Electronic Publication: 2026 Mar 02 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41847707 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Deserti+M%22">Deserti M</searchLink>; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Sabbioni+S%22">Sabbioni S</searchLink>; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Poli+F%22">Poli F</searchLink>; Pathology Unit, Azienda Unità Sanitaria Locale (AUSL) of Imola, Imola, Italy.<br /><searchLink fieldCode="AU" term="%22Vasuri+F%22">Vasuri F</searchLink>; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.; Pathology Unit, Santa Maria delle Croci Ravenna Hospital, Ravenna, Italy.<br /><searchLink fieldCode="AU" term="%22Relli+V%22">Relli V</searchLink>; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Palloni+A%22">Palloni A</searchLink>; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Deiana+C%22">Deiana C</searchLink>; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Brandi+G%22">Brandi G</searchLink>; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Tavolari+S%22">Tavolari S</searchLink>; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Mar 02; Vol. 16, pp. 1713273. <i>Date of Electronic Publication: </i>2026 Mar 02 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41847707 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2026.1713273 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1713273 Titles: – TitleFull: The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Deserti M – PersonEntity: Name: NameFull: Sabbioni S – PersonEntity: Name: NameFull: Poli F – PersonEntity: Name: NameFull: Vasuri F – PersonEntity: Name: NameFull: Relli V – PersonEntity: Name: NameFull: Palloni A – PersonEntity: Name: NameFull: Deiana C – PersonEntity: Name: NameFull: Brandi G – PersonEntity: Name: NameFull: Tavolari S IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 03 Text: 2026 Mar 02 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
